What type of drug is Imfinzi?
Medically reviewed by Drugs.com. Last updated on May 5, 2020.
Imfinzi (durvalumab) is a cancer medicine that works with your immune system to slow cancer cell growth. Imfinzi is classified as an anti-PD-L1 (programmed death ligand-1) human monoclonal antibody.
Learn more: Immune Checkpoint Inhibitors Are Boosting the Cancer Battle
Imfinzi is used to treat:
- Urothelial Carcinoma - a type of cancer in the bladder and urinary tract.
Imfinzi may be used when your urothelial carcinoma that has spread or cannot be removed by surgery, and you have tried chemotherapy that contains platinum, and it did not work or is no longer working.
- Non-Small Cell Lung Cancer (NSCLC) - a type of lung cancer.
Imfinzi may be used when your NSCLC has not spread outside your chest, cannot be removed by surgery, and has responded or stabilized with initial treatment with chemotherapy that contains platinum, given at the same time as radiation therapy.
- Small Cell Lung Cancer (SCLC) - a type of lung cancer.
Imfinzi may be used with the chemotherapy medicines etoposide and carboplatin or cisplatin as your first treatment when your SCLC has spread within your lungs or to other parts of the body, (extensive-stage small cell lung cancer, or ES-SCLC).